Gaixia He

512 total citations
11 papers, 347 citations indexed

About

Gaixia He is a scholar working on Immunology, Epidemiology and Cancer Research. According to data from OpenAlex, Gaixia He has authored 11 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Gaixia He's work include Cancer Genomics and Diagnostics (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Gaixia He is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Gaixia He collaborates with scholars based in China. Gaixia He's co-authors include Xingwang Xie, Lai Wei, Ran Fei, Jinxue Zhou, Hongsong Chen, Henghui Zhang, Yanhui Chen, Yaxian Kong, Beibei Wang and Xueyan Wang and has published in prestigious journals such as Scientific Reports, Journal of Experimental & Clinical Cancer Research and Journal of Gastroenterology and Hepatology.

In The Last Decade

Gaixia He

10 papers receiving 343 citations

Peers

Gaixia He
Liling Qin China
Ruiqi Wu China
Zhubo Chen China
Man Huang China
Christian Quack Germany
Hui-Juan Qiu China
Tan-To Cheung Hong Kong
Anupriya S. Kulkarni United States
Chunlai Yin China
Jinxi Zuo China
Liling Qin China
Gaixia He
Citations per year, relative to Gaixia He Gaixia He (= 1×) peers Liling Qin

Countries citing papers authored by Gaixia He

Since Specialization
Citations

This map shows the geographic impact of Gaixia He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaixia He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaixia He more than expected).

Fields of papers citing papers by Gaixia He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaixia He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaixia He. The network helps show where Gaixia He may publish in the future.

Co-authorship network of co-authors of Gaixia He

This figure shows the co-authorship network connecting the top 25 collaborators of Gaixia He. A scholar is included among the top collaborators of Gaixia He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaixia He. Gaixia He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Zeyu, Fei Du, Nanbin Liu, et al.. (2025). Macrophage DHX34 as a negative regulator of the CX3CL1–CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma. International Immunopharmacology. 169. 116014–116014.
2.
Huang, Li‐Min, Zeyu Li, Qian Wang, et al.. (2025). DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC. Neoplasia. 67. 101198–101198. 1 indexed citations
3.
Liu, Nanbin, Qian Wang, Peng‐Peng Zhu, et al.. (2024). DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation. Journal of Cancer. 15(20). 6594–6615. 3 indexed citations
4.
Zhang, Dan, Gaixia He, Yaping Liu, et al.. (2022). AZD4547 and the Alleviation of Hepatoma Cell Sorafenib Resistance via the Promotionof Autophagy. Anti-Cancer Agents in Medicinal Chemistry. 22(18). 3107–3113. 6 indexed citations
5.
He, Gaixia, Yanhui Chen, Chengpei Zhu, et al.. (2019). Application of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinoma.. PubMed. 11(3). 1428–1445. 23 indexed citations
6.
Zhao, Yangjing, Yanhui Chen, Ying Hu, et al.. (2018). Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing. Translational Cancer Research. 7(2). 231–239. 5 indexed citations
7.
Chen, Yanhui, Ying Hu, Jianghua Wang, et al.. (2018). Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing. Translational Cancer Research. 7(2). 231–239. 12 indexed citations
8.
He, Gaixia, Henghui Zhang, Jinxue Zhou, et al.. (2015). Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 141–141. 217 indexed citations
9.
Yan, Linlin, Henghui Zhang, Hui Ma, et al.. (2015). Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients. Scientific Reports. 5(1). 17950–17950. 16 indexed citations
10.
Hu, Ying, Henghui Zhang, Jing Li, et al.. (2015). Gut‐derived lymphocyte recruitment to liver and induce liver injury in non‐alcoholic fatty liver disease mouse model. Journal of Gastroenterology and Hepatology. 31(3). 676–684. 30 indexed citations
11.
Chen, Yanhui, Weijia Liao, Jinxue Zhou, et al.. (2013). FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China. Journal of Experimental & Clinical Cancer Research. 32(1). 39–39. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liling Qin Breakdown of academic impact, for papers by Ruiqi Wu Breakdown of academic impact, for papers by Zhubo Chen Breakdown of academic impact, for papers by Man Huang Breakdown of academic impact, for papers by Christian Quack Breakdown of academic impact, for papers by Hui-Juan Qiu Breakdown of academic impact, for papers by Tan-To Cheung Breakdown of academic impact, for papers by Anupriya S. Kulkarni Breakdown of academic impact, for papers by Chunlai Yin Breakdown of academic impact, for papers by Jinxi Zuo
Rankless by CCL
2026